Clinical Trials Browser

Phase 2 × Withdrawn × plerixafor × Clear all

NCT04058145 2020-09-07

AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma

Phase 2 Withdrawn

Head and Neck Neoplasms

NCT02682953 2019-12-11

Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers

Phase 2 Withdrawn

LymphoidPlasma cell

Lymphoma, Multiple Myeloma